Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice

Nature Genetics

Volumn 23, Issue 1, 1999, Pages 47-51

  Saigoh, Kazumasa ^a,b   Wang, Yu Lai ^a   Suh, Jun Gyo ^a   Yamanishi, Toshiyuki ^a,b   Sakai, Yoshihisa ^a   Kiyosawa, Hidenori ^a   Harada, Takayuki ^a   Ichihara, Nobutsune ^a   Wakana, Shigeharu ^c   Kikuchi, Tateki ^a   Wada, Keiji ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROLASE; UBIQUITIN;

AGING; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CARBOXY TERMINAL SEQUENCE; CHROMOSOME 5; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; EXON; GENE DELETION; MOUSE; NERVE FIBER DEGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM;

ATAXIA; RODENTIA;

EID: 0032846416     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/12647     Document Type: Article

References (30)

1. Yamazaki, K. et al. Gracile axonal dystrophy (GAD), a new neurological mutant in the mouse. Proc. Soc. Exp. Biol. Med. 187, 209-215 (1988).
2. Mukoyama, M., Yamazaki, K., Kikuchi, T. & Tomita, T. Neuropathology of gracile axonal dystrophy (GAD) mouse (an animal model of central axonopathy in primary sensory neurons). Acta Neuropathol. 79, 294-299 (1989).
3. Kikuchi, T., Mukoyama, M., Yamazaki, K. & Moriya, H. Axonal degeneration of ascending sensory neurons in gracile axonal dystrophy mutant mouse. Acta Neuropathol. (Berl.) 80, 145-151 (1990).
4. Oda, K., Yamazaki, K., Miura, H., Shibasaki, H. & Kikuchi, T. Dying back type axonal degeneration of sensory nerve terminals in muscle spindles of the gracile axonal dystrophy (GAD) mutant mouse. Neuropathol. Appl. Neurobiol. 18, 265-281 (1992).
5. Miura, H. et al. Progressive degeneration of motor nerve terminals in GAD mutant mouse with hereditary sensory axonopathy. Neuropathol. Appl. Neurobiol. 19, 41-51 (1993).
6. Arnold, J. et al. Ubiquitin and its role in neurodegeneration Prog. Brain Res. 117, 23-34 (1998).
7. Alves-Rodrigues, A., Gregori, L. & Figueiredo-Pereira, M.E. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci. 21, 516-520 (1998).
8. Ichihara, N. et al. Axonal degeneration promotes abnormal accumulation of amyloid β-protein in ascending gracile tract of gracile axonal dystrophy (GAD) mouse. Brain Res. 695, 173-178 (1995).
9. Wu, J. et al. Abnormal ubiquitination of dystrophic axons in central nervous system of gracile axonal dystrophy (GAD) mutant mouse. Alzheimer's Res. 2, 163-168 (1996).
10. Yamazaki, K., Sakakibara, A., Tomita, T., Mukoyama, M. & Kikuchi, T. Location of gracile axonal dystrophy (gad) on chromosome 5 of the mouse. Jpn. J. Genet. 62, 479-484 (1987).
11. Suh, J.G., Yamanishi, T., Matsui, K., Tanaka, K. & Wada, K. Mapping of the gracile axonal dystrophy (gad) gene to a region between D5Mit197 and D5Mit113 on proximal mouse chromosome 5. Genomics 27, 549-551 (1995).
12. Day, I.N.M. & Thompson, R.J. Molecular cloning of cDNA coding for human PGP 9.5 protein. A novel cytoplasmic marker for neurones and neuroendocrine cells. FEBS Lett. 210, 157-160 (1987).
13. Wilkinson, K.D. et al. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 246, 670-673 (1989).
14. Day, I.N.M., Hinks, L.J. & Thompson, R.J. The structure of the human gene encoding protein gene product 9.5 (PGP9.5), a neuron-specific ubiquitin C-terminal hydrolase. Biochem. J. 268, 521-524 (1990).
15. Kajimoto, Y. et al. cDNA cloning and tissue distribution of a rat ubiquitin carboxyl-terminal hydrolase PGP9.5. J. Biochem. 112, 28-32 (1992).
16. Larsen, C.N., Price, J.S. & Wilkinson, K.D. Substrate binding and catalysis by ubiquitin C-terminal hydrolases: Identification of two active site residues. Biochemistry 35, 6735-6744 (1996).
17. Dang, L.C., Melandri, F.D. & Stein, R.S. Kinetic and mechanistic studies on the hydrolysis of ubiquitin C-terminal 7-amino-4-methylcoumarin by deubiquitinating enzymes. Biochemistry 37, 1868-1879 (1998).
18. Larsen, C.N., Krantz, B.A. & Wilkinson, K.D. Substrate specificity of deubiquitinating enzyme: ubiquitin C-terminal hydrolases. Biochemistry 37, 3358-3368 (1998).
19. Dietrich, W.F. et al. A genetic map of the mouse with 4,006 simple sequence length polymorphism. Nature Genet. 7, 220-245 (1994).
20. Wakana, S., Shiroishi, T., Puschel, A.W. & Imai, K. The mouse semaphorin F (Semaf) maps to chromosome 15. Mamm. Genome 8, 698-699 (1997).
21. Hershko, A. & Ciechanover, A. The ubiquitin system. Annu. Rev. Biochem. 67, 425-479 (1998).
22. Mayer, A.N. & Wilkinson, K.D. Detection, resolution, and nomenclature of multiple ubiquitin carboxyl-terminal esterases from bovine calf thymus. Biochemistry 28, 166-172 (1989).
23. Wilkinson, K.D., Deshpande, S. & Larsen, C.N. Comparisons of neuronal (PGP 9.5) and non-neuronal ubiquitin C-terminal hydrolases. Biochem. Soc. Trans. 20, 631-637 (1992).
24. Ii, K., Ito, H., Tanaka, K. & Hirano, A. Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly. J. Neuropathol. Exp. Neurol. 56, 125-131 (1997).
25. Leroy, E. et al. The ubiquitin pathway in Parkinson's disease. Nature 395, 451-452 (1998).
26. 2+ channel defects in migraine, ataxia and epilepsy. Trends Pharmacol. Sci. 19, 121-127 (1998).
27. Lowe, J., McDermott, H., Landon, M., Mayer, R.J. & Wilkinson, K.D. Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J. Pathol. 161, 153-160 (1990).
28. Bizzi, A., Schaetzle, B., Patton, A., Gambetti, P. & Autilio-Gambetti, L. Axonal transport of two major components of the ubiquitin system: free ubiquitin and ubiquitin carboxyl-terminal hydrolase PGP 9.5. Brain Res. 548 292-299 (1991).
29. Wenthold, R.J., Yokotani, N., Doi, K. & Wada, K. Immunochemical characterization of the non-NMDA glutamate receptor using subunit-specific antibodies. J. Biol. Chem. 267, 501-507 (1992).
30. Harada, T., Harada, C., Sekiguchi, M. & Wada, K. Light-induced retinal degeneration suppresses developmental progression of flip-to-flop alternative splicing in GluR1. J. Neurosci. 18, 3336-3343 (1998).